Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V)

Adam M Levinson1, John H McGee2, Andrew G Roberts

  • 1Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College , New York, New York 10065, United States.

Insights

Researchers synthesized mirror-image forms of cancer-driving Ras proteins (KRas). These enantiomeric proteins can fold and bind molecules, enabling new therapeutic strategies against difficult cancer targets.

Area of Science:

  • Biochemistry
  • Chemical Biology
  • Oncology

Background:

  • Ras proteins are crucial GTPases regulating cell growth and survival.
  • Mutated Ras proteins are implicated in ~30% of human cancers, driving uncontrolled proliferation.
  • Ras has been historically challenging to target therapeutically due to its biochemical properties.

Purpose of the Study:

  • To achieve total chemical synthesis of all-l- and all-d-amino acid variants of oncogenic KRas(G12V).
  • To investigate the biochemical properties and functional competency of these enantiomeric Ras proteins.
  • To establish a foundation for developing novel therapeutic strategies against oncogenic Ras.

Main Methods:

  • Fmoc-based solid-phase peptide synthesis was employed for protein construction.
  • Native chemical ligation and isonitrile-mediated activation were used for assembly.
  • Enantiomeric KRas(G12V) variants were synthesized and biochemically characterized.

Main Results:

  • Successfully synthesized all-l- and all-d-amino acid biotinylated KRas(G12V) variants.
  • Demonstrated that both enantiomers of KRas(G12V) can fold and bind nucleotide substrates.
  • Observed enantiodiscrimination in nucleotide substrate and binding partner interactions.

Conclusions:

  • The synthesis and functional validation of enantiomeric KRas provide a novel biochemical tool.
  • This work enables mirror-image yeast surface display for identifying all-d peptide ligands.
  • These findings offer a promising new avenue for developing therapeutics against oncogenic KRas.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...